We are monitoring the impact of COVID-19 on Asia Pacific Medical Cannabis Market Get in touch with us for detailed analysis Know More
Pulished Date April, 2021
ID: 9869
Share on
Share on

Asia Pacific Medical Cannabis Market Research Report - Segmented By Species, Derivatives, Application, Route of Administration & Country (India, China, Japan, South Korea, Australia & New Zealand, Thailand, Malaysia, Vietnam, Philippines, Indonesia, Singapore & Rest of APAC) – Industry Size, Share, Trends & Growth Forecast (2021 to 2026)

Pulished: April, 2021
ID: 9869
Pages: 100

APAC Medical Cannabis Market Size (2021 to 2026):

The Medical cannabis market in the Asia Pacific is forecasted to hike at a decent rate between 2021 to 2026.

Increasing R & D activities for drug discovery using medical cannabis, rising incidence of chronic diseases such as cancer, osteoarthritis, and other diseases in Asia-Pacific countries, and increasing awareness regarding the benefits associated with medical cannabis are majorly propelling the medical cannabis market in the Asia-Pacific.

Increasing cannabis authorization and R & D activities in the medical cannabis sector for drug delivery are expected to add fuel to the market growth. For instance, in January 2018, the Australian government enabled cannabis manufacturers to market and legalized the products' shipment to a few countries. The usage of cannabis in clinical studies to generate drug formulas for cancer treatment and pain management for the increasing aging population of Asia Pacific countries are further contributing to the growth of the market. Moreover, growing investments from the global players operating in the cannabis domain such as Net Savings Link Inc. and vast plantation of cannabis in various parts of China is additionally expected to favor the Asia-Pacific medical cannabis market.

Rising acceptance of medical cannabis, increasing discretionary expenses, and increasing expenses towards healthcare are positive signs to the growth rate of the market. 

Strict government laws in Asia-pacific countries such as India, China, and Japan to manufacture medical cannabis is a significant obstacle to the growth rate of the market to unleash completely. Side effects, such as heart attacks and tachycardia, are associated with a massive intake of cannabis that are likely to hinder the growth of the medical cannabis market in Asia-Pacific during the forecast period. 

This research report on the Asia-Pacific medical cannabis market has been segmented and sub-segmented into the following categories:

By Species: 

  • Indica
  • Satiiva
  • Hybrid

By Derivatives: 

  • Cannabidiol (CBD)
  • Tetrahydrocannabinol (THC)
  • Others

By Application: 

  • Cancer
  • Arthritis
  • Epilepsy
  • Migraine

By End User: 

  • Pharmaceutical Industry
  • Research and Development Centres
  • Others

By Route of Administration: 

  • Oral Solutions and Capsules
  • Smoking
  • Vaporizers
  • Topicals
  • Others

By Country: 

  • India
  • China
  • Japan
  • South Korea
  • Australia & New Zealand
  • Thailand
  • Malaysia
  • Vietnam
  • Philippines
  • Indonesia
  • Singapore
  • Rest of APAC

REGIONAL ANALYSIS:

The medical cannabis market in the APAC region is anticipated to grow with the highest CAGR over this region's analysis period. The market growth is attributed to factors like the growing number of cancers, osteoarthritis, and other diseases. Countries like China, India, Japan, South Korea, Australia, Singapore, and other APAC region countries.

Australian Medical Cannabis Market is leading the market and has the largest share in APAC and is expected to grow in the coming years. It is the first country of APAC to introduce a countrywide medicinal cannabis framework. 

South Korea Medical Cannabis Market is expected to grow in the medical cannabis market over the forthcoming years significantly. This country's growth is owed to increasing awareness and a growing number of people with chronic diseases that bolster the medical cannabis market growth in the APAC region.

The medical cannabis market in China has strict regulations opposing the sale of these cannabis products in the market. The population in China has a high demand for cannabidiol, which will foster in the future. 

Simultaneously, the Indian medical cannabis market has also got strict regulations that have noticed the legal usage of cannabis production. In India, countries like UP and Uttarakhand states have received Hemp Cultivation licenses. Moreover, Indian based healthcare start-up, Hemp Street, concentrates on cannabis usage, particularly in Ayurveda medicine.

Some of the notable companies playing a significant role in the APAC Medical Cannabis Market Profiled in the Report are BOL Pharma, Tilray, Medreleaf Corporation, Aurora Cannabis, Inc., Canopy Growth Corporation, Insys Therapeutics, Inc., Aphria, Inc., MGC Pharmaceuticals Limited, GW Pharmaceuticals, plc.

  1. Introduction
    1. Asia Pacific Medical Cannabis Market Definition
    2. Study Deliverables
    3. Base Currency, Base Year and Forecast Periods
    4. General Study Assumptions
  2. Research Methodology
    1. Introduction
    2. Research Phases
        1. Secondary Research
        2. Primary Research
        3. Econometric Modelling
        4. Expert Validation
    3. Analysis Design
    4. Study Timeline
  3. Overview
    1. Executive Summary
    2. Key Inferences
    3. New Developments
  4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)
    1. Asia Pacific Medical Cannabis Market Drivers
    2. Asia Pacific Medical Cannabis Market Restraints
    3. Key Challenges
    4. Current Opportunities in the Market
  5. Asia Pacific Medical Cannabis Market Segmentation
    1. By Species
      1. Indica
      2. Satiiva
      3. Hybrid
      4. Y-o-Y Growth Analysis, By Species
      5. Asia Pacific Medical Cannabis Market Attractiveness Analysis, By Species
      6. Asia Pacific Medical Cannabis Market Share Analysis, By Species
    2. By Derivatives
      1. Cannabidiol (CBD)
      2. Tetrahydrocannabinol (THC)
      3. Others
      4. Y-o-Y Growth Analysis, By Derivatives
      5. Asia Pacific Medical Cannabis Market Attractiveness Analysis, By Derivatives
      6. Asia Pacific Medical Cannabis Market Share Analysis, By Derivatives
    3. By Application
      1. Cancer
      2. Arthritis
      3. Epilepsy
      4. Migraine
      5. Y-o-Y Growth Analysis, By Application
      6. Asia Pacific Medical Cannabis Market Attractiveness Analysis, By Application
      7. Asia Pacific Medical Cannabis Market Share Analysis, By Application
    4. By End User
      1. Pharmaceutical Industry
      2. Research and Development Centers
      3. Others
      4. Y-o-Y Growth Analysis, By End User
      5. Asia Pacific Medical Cannabis Market Attractiveness Analysis, By End User
      6. Asia Pacific Medical Cannabis Market Share Analysis, By End User
    5. By Route of Administration
      1. Oral Solutions and Capsules
      2. Smoking
      3. Vaporizers
      4. Topicals
      5. Y-o-Y Growth Analysis, By Route of Administration
      6. Asia Pacific Medical Cannabis Market Attractiveness Analysis, Route of Administration
      7. Asia Pacific Medical Cannabis Market Share Analysis, Route of Administration
  6. Geographical Analysis
    1. Introduction    
      1. Regional Trends   
      2. Impact Analysis    
      3. Y-o-Y Growth Analysis        
        1. By Geographical Area
        2. By Species
        3. By Derivatives
        4. By Application
        5. By End-User
        6. By Route of Administration
      4. Asia Pacific Medical Cannabis Market Attractiveness Analysis 
        1. By Geographical Area
        2. By Species
        3. By Derivatives
        4. By Application
        5. By End-User
        6. By Route of Administration
      5.      Asia Pacific Medical Cannabis Market Share Analysis              
        1. By Geographical Area
        2. By Species
        3. By Derivatives
        4. By Application
        5. By End-User
        6. By Route of Administration
    2. Asia-Pacific
      1. Introduction
      2. India
      3. China
      4. Japan
      5. South Korea
      6. Australia
  7. Strategic Analysis
    1. PESTLE analysis
      1. Political
      2. Economic
      3. Social
      4. Technological
      5. Legal
      6. Environmental
    2. Porter’s Five analysis
      1. Bargaining Power of Suppliers
      2. Bargaining Power of Consumers
      3. Threat of New Entrants
      4. Threat of Substitute Products and Services
      5. Competitive Rivalry within the Industry
  8. Asia Pacific Medical Cannabis Market Leaders' Analysis
    1. BOL Pharma
      1. Overview
      2. Product Analysis
      3. Strategic Evaluation and Operations
      4. Financial analysis
      5. Legal issues
      6. Recent Developments
      7. SWOT analysis
      8. Analyst View
    2. Tilray
    3. Medreleaf Corporation
    4. Aurora Cannabis, Inc
    5. Canopy Growth Corporation
    6. Insys Therapeutics, Inc
    7. Aphria, Inc
    8. MGC Pharmaceuticals Limited
    9. GW Pharmaceuticals, plc
  9. Competitive Landscape
    1. Asia Pacific Medical Cannabis Market share analysis
    2. Merger and Acquisition Analysis
    3. Agreements, Collaborations and Joint Ventures
    4. New Product Launches
  10. Asia Pacific Medical Cannabis Market Outlook and Investment Opportunities
  11. Appendix
    1. List of Tables
    2. List of Figures  

 

  • Regional and country-level analysis and forecasts of the study market; providing Insights on the major countries/regions in which this industry is blooming and to also identify the regions that are still untapped.
  • Segment-level analysis in terms of Type, application, end user and region along with market size forecasts and estimations to detect key areas of industry growth in detail.
  • Identification of key drivers, restraints, opportunities and challenges (DROC) in the market and their impact on shifting market dynamics.
  • Study of the effect of exogenous and endogenous factors that affect the global market; which includes broadly demographic, economic and political, among other macro-environmental factors presented in an extensive PESTLE Analysis.
  • Study the micro environment factors that determine the overall profitability of an Industry, using Porter’s five forces analysis for analyzing the level of competition and business strategy development.
  • A comprehensive list of key market players along with their product portfolio, current strategic interests, key financial information, legal issues, SWOT analysis and analyst overview to study and sustain the market environment.
  • Competitive landscape analysis listing out the mergers, acquisitions, collaborations in the field along with new product launches, comparative financial studies and recent developments in the market by the major companies.
  • An executive summary, abridging the entire report in such a way that decision-making personnel can rapidly become acquainted with background information, concise analysis and main conclusions.
  • Expertly devised analyst overview along with Investment opportunities to provide both individuals and organizations a strong financial foothold in the market.

 

  1. Asia Pacific Medical Cannabis Market Market By Species, From 2021 to 2026 ( USD Million )
  2. Asia Pacific Indica Market By Region, From 2021 to 2026 ( USD Million )
  3. Asia Pacific Satiiva Market By Region, From 2021 to 2026 ( USD Million )
  4. Asia Pacific Hybrid Market By Region, From 2021 to 2026 ( USD Million )
  5. Asia Pacific Medical Cannabis Market Market By Derivatives, From 2021 to 2026 ( USD Million )
  6. Asia Pacific Cannabidiol (CBD) Market By Region, From 2021 to 2026 ( USD Million )
  7. Asia Pacific Tetrahydrocannabinol (THC) Market By Region, From 2021 to 2026 ( USD Million )
  8. Asia Pacific Others Market By Region, From 2021 to 2026 ( USD Million )
  9. Asia Pacific Medical Cannabis Market Market By Application, From 2021 to 2026 ( USD Million )
  10. Asia Pacific Cancer Market By Region, From 2021 to 2026 ( USD Million )
  11. Asia Pacific Arthritis Market By Region, From 2021 to 2026 ( USD Million )
  12. Asia Pacific Epilespy Market By Region, From 2021 to 2026 ( USD Million )
  13. Asia Pacific Migraine Market By Region, From 2021 to 2026 ( USD Million )
  14. Asia Pacific Medical Cannabis Market Market By End-User, From 2021 to 2026 ( USD Million )
  15. Asia Pacific Pharmaceutical Industry Market By Region, From 2021 to 2026 ( USD Million )
  16. Asia Pacific Research and Development Centers Market By Region, From 2021 to 2026 ( USD Million )
  17. Asia Pacific others Market By Region, From 2021 to 2026 ( USD Million )
  18. Asia Pacific Medical Cannabis Market Market By Route of Administration, From 2021 to 2026 ( USD Million )
  19. Asia Pacific Oral Solutions and Capsules Market By Region, From 2021 to 2026 ( USD Million )
  20. Asia Pacific Smoking Market By Region, From 2021 to 2026 ( USD Million )
  21. Asia Pacific Vaporizers Market By Region, From 2021 to 2026 ( USD Million )
  22. Asia Pacific Topicals Market By Region, From 2021 to 2026 ( USD Million )
  23. Asia Pacific others Market By Region, From 2021 to 2026 ( USD Million )
  24. Japan Medical Cannabis Market Market By Species, From 2021 to 2026 ( USD Million )
  25. Japan Medical Cannabis Market Market By Derivatives, From 2021 to 2026 ( USD Million )
  26. Japan Medical Cannabis Market Market By Application, From 2021 to 2026 ( USD Million )
  27. Japan Medical Cannabis Market Market By End-User, From 2021 to 2026 ( USD Million )
  28. Japan Medical Cannabis Market Market By Route of Administration, From 2021 to 2026 ( USD Million )
  29. China Medical Cannabis Market Market By Species, From 2021 to 2026 ( USD Million )
  30. China Medical Cannabis Market Market By Derivatives, From 2021 to 2026 ( USD Million )
  31. China Medical Cannabis Market Market By Application, From 2021 to 2026 ( USD Million )
  32. China Medical Cannabis Market Market By End-User, From 2021 to 2026 ( USD Million )
  33. China Medical Cannabis Market Market By Route of Administration, From 2021 to 2026 ( USD Million )
  34. India Medical Cannabis Market Market By Species, From 2021 to 2026 ( USD Million )
  35. India Medical Cannabis Market Market By Derivatives, From 2021 to 2026 ( USD Million )
  36. India Medical Cannabis Market Market By Application, From 2021 to 2026 ( USD Million )
  37. India Medical Cannabis Market Market By End-User, From 2021 to 2026 ( USD Million )
  38. India Medical Cannabis Market Market By Route of Administration, From 2021 to 2026 ( USD Million )
  39. Australia Medical Cannabis Market Market By Species, From 2021 to 2026 ( USD Million )
  40. Australia Medical Cannabis Market Market By Derivatives, From 2021 to 2026 ( USD Million )
  41. Australia Medical Cannabis Market Market By Application, From 2021 to 2026 ( USD Million )
  42. Australia Medical Cannabis Market Market By End-User, From 2021 to 2026 ( USD Million )
  43. Australia Medical Cannabis Market Market By Route of Administration, From 2021 to 2026 ( USD Million )
  44. South Korea Medical Cannabis Market Market By Species, From 2021 to 2026 ( USD Million )
  45. South Korea Medical Cannabis Market Market By Derivatives, From 2021 to 2026 ( USD Million )
  46. South Korea Medical Cannabis Market Market By Application, From 2021 to 2026 ( USD Million )
  47. South Korea Medical Cannabis Market Market By End-User, From 2021 to 2026 ( USD Million )
  48. South Korea Medical Cannabis Market Market By Route of Administration, From 2021 to 2026 ( USD Million )

Please wait. . . . Your request is being processed

Related Reports

LICENCE TYPE

$ 1234 3335

Clients
clients
clients
clients
clients
clients
clients
Click for Request Sample